Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Beximco Pharmaceuticals Limited (BXP.LN)

Beximco Pharmaceuticals Limited (BXP.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Beximco Pharmaceuticals Limited 19 Dhanmondi, Road No. 7 Dhaka 1205 BGD

https://www.beximcopharma.com P: 880-258-6110 F: 880-258-6146

Description:

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Key Statistics

Overview:

Market Capitalization, $K 372,285
Shares Outstanding, K 446,112
Annual Sales, $ 39,267 M
Annual Net Income, $ 4,614 M
Last Quarter Sales, $ 10,904 M
Last Quarter Net Income, $ 1,433 M
% of Insider Shareholders 4.20%
% of Institutional Shareholders 1.22%

Growth:

1-Year Return -17.98%
3-Year Return -57.31%
5-Year Return -19.70%
5-Year Revenue Growth 17.25%
5-Year Earnings Growth 12.72%
5-Year Dividend Growth 24.26%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 11.01
EPS Growth vs. Prev Qtr 2.82%
EPS Growth vs. Prev Year -0.10%
Annual Dividend Rate, $ 3.55
Annual Dividend Yield 6.89%
Most Recent Dividend 0.032 on 11/10/23
Next Ex-Dividends Date 11/10/23
Dividend Payable Date 02/08/24
Dividend Payout Ratio 32.26%
Most Recent Split 110-100 on 11/23/20

BXP.LN Ratios

Ratio
Price/Earnings ttm 4.63
Price/Earnings forward N/A
Return-on-Equity % 11.32%
Return-on-Assets % 7.03%
Profit Margin % 11.75%
Debt/Equity 0.06
Price/Sales 0.55
Price/Book 0.50
Book Value/Share 0.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar